Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus

<table>The percentage of PBMCs, lymphocytes B CD19<sup>+</sup>, and lymphocytes T CD3<sup>+</sup>, including CD4<sup>+</sup> and CD8<sup>+</sup>, expressing TLR3 in patients with SLE and healthy controls.</table>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus 